Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-10-01

AUTHORS

Ryota Kakizaki, Yoshiyasu Minami, Masahiro Katamine, Aritomo Katsura, Yusuke Muramatsu, Takuya Hashimoto, Kentaro Meguro, Takao Shimohama, Junya Ako

ABSTRACT

BackgroundDiabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, we aimed to compare the clinical outcomes between patients treated with the biodegradable polymer sirolimus-eluting stents (BP-SES) and the durable polymer everolimus-eluting stents (DP-EES) among patients with diabetes.MethodsAmong 631 lesions in 510 consecutive patients treated with either BP-SES or DP-EES, 165 lesions in 141 patients with diabetes mellitus and stable angina pectoris were identified and classified into the BP-SES group (48 lesions in 44 patients) and the DP-EES group (117 lesions in 100 patients). The incidence of adverse clinical events after stent implantation was compared between the 2 groups.ResultsThere was no significant difference in the prevalence of conventional risk factors, lesion characteristics, and procedural characteristics between the 2 groups. During median 386 [334–472] days follow-up, the incidence of target lesion revascularization (11.4 vs. 2.0%, p = 0.003) and device-oriented clinical endpoint (13.6 vs. 6.0%, p = 0.035) in the BP-SES group was significantly greater than that in the DP-EES group. A univariate model demonstrated that the BP-SES usage was significantly associated with the higher incidence of target lesion revascularization (odds ratio, 6.686; 95% confidence interval, 1.234–36.217; p = 0.028).ConclusionBP-SES was associated with the greater incidence of TLR than the DP-EES in patients with diabetes mellitus. Further studies with larger cohorts and longer follow-up are required to confirm the present results. More... »

PAGES

162

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12933-020-01145-x

DOI

http://dx.doi.org/10.1186/s12933-020-01145-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1131361307

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33004019


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angina, Stable", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakizaki", 
        "givenName": "Ryota", 
        "id": "sg:person.010156707735.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010156707735.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minami", 
        "givenName": "Yoshiyasu", 
        "id": "sg:person.01336006602.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336006602.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Katamine", 
        "givenName": "Masahiro", 
        "id": "sg:person.015044447460.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015044447460.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Katsura", 
        "givenName": "Aritomo", 
        "id": "sg:person.012150654667.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012150654667.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muramatsu", 
        "givenName": "Yusuke", 
        "id": "sg:person.014023446777.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014023446777.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hashimoto", 
        "givenName": "Takuya", 
        "id": "sg:person.01105601162.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105601162.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meguro", 
        "givenName": "Kentaro", 
        "id": "sg:person.016506421751.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016506421751.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimohama", 
        "givenName": "Takao", 
        "id": "sg:person.01116550365.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116550365.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ako", 
        "givenName": "Junya", 
        "id": "sg:person.0744472011.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744472011.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12933-019-0827-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1112673031", 
          "https://doi.org/10.1186/s12933-019-0827-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12933-018-0758-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106156906", 
          "https://doi.org/10.1186/s12933-018-0758-0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-10-01", 
    "datePublishedReg": "2020-10-01", 
    "description": "BackgroundDiabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, we aimed to compare the clinical outcomes between patients treated with the biodegradable polymer sirolimus-eluting stents (BP-SES) and the durable polymer everolimus-eluting stents (DP-EES) among patients with diabetes.MethodsAmong 631 lesions in 510 consecutive patients treated with either BP-SES or DP-EES, 165 lesions in 141 patients with diabetes mellitus and stable angina pectoris were identified and classified into the BP-SES group (48 lesions in 44 patients) and the DP-EES group (117 lesions in 100 patients). The incidence of adverse clinical events after stent implantation was compared between the 2 groups.ResultsThere was no significant difference in the prevalence of conventional risk factors, lesion characteristics, and procedural characteristics between the 2 groups. During median 386 [334\u2013472] days follow-up, the incidence of target lesion revascularization (11.4 vs. 2.0%, p\u2009=\u20090.003) and device-oriented clinical endpoint (13.6 vs. 6.0%, p\u2009=\u20090.035) in the BP-SES group was significantly greater than that in the DP-EES group. A univariate model demonstrated that the BP-SES usage was significantly associated with the higher incidence of target lesion revascularization (odds ratio, 6.686; 95% confidence interval, 1.234\u201336.217; p\u2009=\u20090.028).ConclusionBP-SES was associated with the greater incidence of TLR than the DP-EES in patients with diabetes mellitus. Further studies with larger cohorts and longer follow-up are required to confirm the present results.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12933-020-01145-x", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031021", 
        "issn": [
          "1475-2840"
        ], 
        "name": "Cardiovascular Diabetology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "durable polymer everolimus-eluting stents", 
      "biodegradable polymer sirolimus-eluting stents", 
      "adverse clinical events", 
      "BP-SES group", 
      "DP-EES group", 
      "target lesion revascularization", 
      "everolimus-eluting stents", 
      "clinical events", 
      "lesion revascularization", 
      "diabetes mellitus", 
      "clinical outcomes", 
      "stable angina pectoris", 
      "percutaneous coronary intervention", 
      "conventional risk factors", 
      "sirolimus-eluting stents", 
      "BackgroundDiabetes mellitus", 
      "coronary intervention", 
      "consecutive patients", 
      "angina pectoris", 
      "stent implantation", 
      "risk factors", 
      "clinical endpoints", 
      "lesion characteristics", 
      "procedural characteristics", 
      "large cohort", 
      "high incidence", 
      "patients", 
      "stent type", 
      "greater incidence", 
      "mellitus", 
      "incidence", 
      "diabetes", 
      "stents", 
      "revascularization", 
      "significant differences", 
      "Further studies", 
      "lesions", 
      "present study", 
      "outcomes", 
      "group", 
      "univariate models", 
      "pectoris", 
      "ResultsThere", 
      "TLR", 
      "cohort", 
      "present results", 
      "prevalence", 
      "endpoint", 
      "intervention", 
      "events", 
      "differences", 
      "implantation", 
      "risk", 
      "study", 
      "days", 
      "factors", 
      "characteristics", 
      "types", 
      "results", 
      "usage", 
      "model", 
      "biodegradable polymers", 
      "polymers"
    ], 
    "name": "Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes", 
    "pagination": "162", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1131361307"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12933-020-01145-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33004019"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12933-020-01145-x", 
      "https://app.dimensions.ai/details/publication/pub.1131361307"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_866.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12933-020-01145-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12933-020-01145-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12933-020-01145-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12933-020-01145-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12933-020-01145-x'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      21 PREDICATES      111 URIs      101 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12933-020-01145-x schema:about N0c732b00bb7a424ca4c25439444dcc73
2 N1382ec3ee176423ca37119f0300ce26c
3 N13a73bbd798a457ab2ed03b690e0d2d2
4 N173dbbb304e24fb09420dc06f247ac6c
5 N1e4525db15e94202a20e834ba3fc2ad5
6 N2785ec667d054573982f98a2089b9884
7 N3dea914ba8b94353acc645e09be026df
8 N4acdb33fa50d459e8a8bd3ec05b14f83
9 N7c7a543afe004442a4290b910e77e3cf
10 N823308e255fa422e8104b9cae0f16ea1
11 Na68384b7592d4c9a89dab9f8012477eb
12 Naa8e4b7b5f584bac82b633657db2fafc
13 Naf5fb4a822c648859d1fc88cef7ba3c8
14 Nbfd09b8feb354261943e476c62e88689
15 Nc40b5e1dff984bc3907fa3290f17f09a
16 Ne3ded25c20304d1289391fc7635767a1
17 Ne769d9b42a7945c5a5937cd1d013e178
18 Ne9bc4091dff04df1989dc723c0113d36
19 Nf0f3eaa43de84b16bdc4de348b2ccfde
20 Nf32bbbc7b44349d49a04b3f642ded2b6
21 Nf6b6fe854bf443adadac4c6d8f19d79d
22 anzsrc-for:11
23 anzsrc-for:1103
24 schema:author N51dddbc51788408b96428de90a7816d7
25 schema:citation sg:pub.10.1186/s12933-018-0758-0
26 sg:pub.10.1186/s12933-019-0827-z
27 schema:datePublished 2020-10-01
28 schema:datePublishedReg 2020-10-01
29 schema:description BackgroundDiabetes mellitus is a risk for increased incidence of adverse clinical events after percutaneous coronary intervention. However, the difference in the incidence of adverse clinical events according to stent type in patients with diabetes remains to be elucidated. In the present study, we aimed to compare the clinical outcomes between patients treated with the biodegradable polymer sirolimus-eluting stents (BP-SES) and the durable polymer everolimus-eluting stents (DP-EES) among patients with diabetes.MethodsAmong 631 lesions in 510 consecutive patients treated with either BP-SES or DP-EES, 165 lesions in 141 patients with diabetes mellitus and stable angina pectoris were identified and classified into the BP-SES group (48 lesions in 44 patients) and the DP-EES group (117 lesions in 100 patients). The incidence of adverse clinical events after stent implantation was compared between the 2 groups.ResultsThere was no significant difference in the prevalence of conventional risk factors, lesion characteristics, and procedural characteristics between the 2 groups. During median 386 [334–472] days follow-up, the incidence of target lesion revascularization (11.4 vs. 2.0%, p = 0.003) and device-oriented clinical endpoint (13.6 vs. 6.0%, p = 0.035) in the BP-SES group was significantly greater than that in the DP-EES group. A univariate model demonstrated that the BP-SES usage was significantly associated with the higher incidence of target lesion revascularization (odds ratio, 6.686; 95% confidence interval, 1.234–36.217; p = 0.028).ConclusionBP-SES was associated with the greater incidence of TLR than the DP-EES in patients with diabetes mellitus. Further studies with larger cohorts and longer follow-up are required to confirm the present results.
30 schema:genre article
31 schema:isAccessibleForFree true
32 schema:isPartOf N2e8a0e87810744ec8f9151e00755b0b8
33 Nbedac5cb8a574cb98f93f24ffa609e27
34 sg:journal.1031021
35 schema:keywords BP-SES group
36 BackgroundDiabetes mellitus
37 DP-EES group
38 Further studies
39 ResultsThere
40 TLR
41 adverse clinical events
42 angina pectoris
43 biodegradable polymer sirolimus-eluting stents
44 biodegradable polymers
45 characteristics
46 clinical endpoints
47 clinical events
48 clinical outcomes
49 cohort
50 consecutive patients
51 conventional risk factors
52 coronary intervention
53 days
54 diabetes
55 diabetes mellitus
56 differences
57 durable polymer everolimus-eluting stents
58 endpoint
59 events
60 everolimus-eluting stents
61 factors
62 greater incidence
63 group
64 high incidence
65 implantation
66 incidence
67 intervention
68 large cohort
69 lesion characteristics
70 lesion revascularization
71 lesions
72 mellitus
73 model
74 outcomes
75 patients
76 pectoris
77 percutaneous coronary intervention
78 polymers
79 present results
80 present study
81 prevalence
82 procedural characteristics
83 results
84 revascularization
85 risk
86 risk factors
87 significant differences
88 sirolimus-eluting stents
89 stable angina pectoris
90 stent implantation
91 stent type
92 stents
93 study
94 target lesion revascularization
95 types
96 univariate models
97 usage
98 schema:name Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
99 schema:pagination 162
100 schema:productId N11531d4062f9405abcab40dca6b9647b
101 N7bb28810e54e4794a46711da2f47eb94
102 Ncfd98b7c201547b2bf6e44dd9fd5283f
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1131361307
104 https://doi.org/10.1186/s12933-020-01145-x
105 schema:sdDatePublished 2022-12-01T06:41
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Nd17c74475370452bbbf681d3d8b5776f
108 schema:url https://doi.org/10.1186/s12933-020-01145-x
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N088dcf16048440d2b8f15b5911f6a697 rdf:first sg:person.01336006602.59
113 rdf:rest Nf9c89bdca7c84df5807b24a83c9bfa1c
114 N0c732b00bb7a424ca4c25439444dcc73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Male
116 rdf:type schema:DefinedTerm
117 N11531d4062f9405abcab40dca6b9647b schema:name doi
118 schema:value 10.1186/s12933-020-01145-x
119 rdf:type schema:PropertyValue
120 N1382ec3ee176423ca37119f0300ce26c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Coronary Artery Disease
122 rdf:type schema:DefinedTerm
123 N13a73bbd798a457ab2ed03b690e0d2d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Sirolimus
125 rdf:type schema:DefinedTerm
126 N173dbbb304e24fb09420dc06f247ac6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Cardiovascular Agents
128 rdf:type schema:DefinedTerm
129 N1e4525db15e94202a20e834ba3fc2ad5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Aged
131 rdf:type schema:DefinedTerm
132 N2785ec667d054573982f98a2089b9884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Drug-Eluting Stents
134 rdf:type schema:DefinedTerm
135 N2e8a0e87810744ec8f9151e00755b0b8 schema:issueNumber 1
136 rdf:type schema:PublicationIssue
137 N3dea914ba8b94353acc645e09be026df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Everolimus
139 rdf:type schema:DefinedTerm
140 N3f8e883a2cae46b58ee2fbae9aaaacbe rdf:first sg:person.012150654667.06
141 rdf:rest N8e90a86d0abd499da4acdb6e33166078
142 N4acdb33fa50d459e8a8bd3ec05b14f83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Treatment Outcome
144 rdf:type schema:DefinedTerm
145 N51dddbc51788408b96428de90a7816d7 rdf:first sg:person.010156707735.27
146 rdf:rest N088dcf16048440d2b8f15b5911f6a697
147 N7bb28810e54e4794a46711da2f47eb94 schema:name dimensions_id
148 schema:value pub.1131361307
149 rdf:type schema:PropertyValue
150 N7c7a543afe004442a4290b910e77e3cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Middle Aged
152 rdf:type schema:DefinedTerm
153 N823308e255fa422e8104b9cae0f16ea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Diabetes Mellitus
155 rdf:type schema:DefinedTerm
156 N8e90a86d0abd499da4acdb6e33166078 rdf:first sg:person.014023446777.64
157 rdf:rest Nd5f7b80f067c403f8d9635ca6e78ead8
158 Na68384b7592d4c9a89dab9f8012477eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Angina, Stable
160 rdf:type schema:DefinedTerm
161 Naa8e4b7b5f584bac82b633657db2fafc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Risk Assessment
163 rdf:type schema:DefinedTerm
164 Naf5fb4a822c648859d1fc88cef7ba3c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Humans
166 rdf:type schema:DefinedTerm
167 Nbedac5cb8a574cb98f93f24ffa609e27 schema:volumeNumber 19
168 rdf:type schema:PublicationVolume
169 Nbfd09b8feb354261943e476c62e88689 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Retrospective Studies
171 rdf:type schema:DefinedTerm
172 Nc40b5e1dff984bc3907fa3290f17f09a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Prosthesis Design
174 rdf:type schema:DefinedTerm
175 Ncfd98b7c201547b2bf6e44dd9fd5283f schema:name pubmed_id
176 schema:value 33004019
177 rdf:type schema:PropertyValue
178 Nd17c74475370452bbbf681d3d8b5776f schema:name Springer Nature - SN SciGraph project
179 rdf:type schema:Organization
180 Nd346e395c5b74562b590edde8fa5a6b1 rdf:first sg:person.0744472011.56
181 rdf:rest rdf:nil
182 Nd5f7b80f067c403f8d9635ca6e78ead8 rdf:first sg:person.01105601162.18
183 rdf:rest Ndc7854e073254d139889c6e46578c26a
184 Ndc7854e073254d139889c6e46578c26a rdf:first sg:person.016506421751.89
185 rdf:rest Nee1a95ac0529424881aab06c82961cfc
186 Ne3ded25c20304d1289391fc7635767a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Female
188 rdf:type schema:DefinedTerm
189 Ne769d9b42a7945c5a5937cd1d013e178 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Japan
191 rdf:type schema:DefinedTerm
192 Ne9bc4091dff04df1989dc723c0113d36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Percutaneous Coronary Intervention
194 rdf:type schema:DefinedTerm
195 Nee1a95ac0529424881aab06c82961cfc rdf:first sg:person.01116550365.77
196 rdf:rest Nd346e395c5b74562b590edde8fa5a6b1
197 Nf0f3eaa43de84b16bdc4de348b2ccfde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Polymers
199 rdf:type schema:DefinedTerm
200 Nf32bbbc7b44349d49a04b3f642ded2b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Risk Factors
202 rdf:type schema:DefinedTerm
203 Nf6b6fe854bf443adadac4c6d8f19d79d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Time Factors
205 rdf:type schema:DefinedTerm
206 Nf9c89bdca7c84df5807b24a83c9bfa1c rdf:first sg:person.015044447460.76
207 rdf:rest N3f8e883a2cae46b58ee2fbae9aaaacbe
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
212 schema:name Clinical Sciences
213 rdf:type schema:DefinedTerm
214 sg:journal.1031021 schema:issn 1475-2840
215 schema:name Cardiovascular Diabetology
216 schema:publisher Springer Nature
217 rdf:type schema:Periodical
218 sg:person.010156707735.27 schema:affiliation grid-institutes:grid.410786.c
219 schema:familyName Kakizaki
220 schema:givenName Ryota
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010156707735.27
222 rdf:type schema:Person
223 sg:person.01105601162.18 schema:affiliation grid-institutes:grid.410786.c
224 schema:familyName Hashimoto
225 schema:givenName Takuya
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105601162.18
227 rdf:type schema:Person
228 sg:person.01116550365.77 schema:affiliation grid-institutes:grid.410786.c
229 schema:familyName Shimohama
230 schema:givenName Takao
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116550365.77
232 rdf:type schema:Person
233 sg:person.012150654667.06 schema:affiliation grid-institutes:grid.410786.c
234 schema:familyName Katsura
235 schema:givenName Aritomo
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012150654667.06
237 rdf:type schema:Person
238 sg:person.01336006602.59 schema:affiliation grid-institutes:grid.410786.c
239 schema:familyName Minami
240 schema:givenName Yoshiyasu
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336006602.59
242 rdf:type schema:Person
243 sg:person.014023446777.64 schema:affiliation grid-institutes:grid.410786.c
244 schema:familyName Muramatsu
245 schema:givenName Yusuke
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014023446777.64
247 rdf:type schema:Person
248 sg:person.015044447460.76 schema:affiliation grid-institutes:grid.410786.c
249 schema:familyName Katamine
250 schema:givenName Masahiro
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015044447460.76
252 rdf:type schema:Person
253 sg:person.016506421751.89 schema:affiliation grid-institutes:grid.410786.c
254 schema:familyName Meguro
255 schema:givenName Kentaro
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016506421751.89
257 rdf:type schema:Person
258 sg:person.0744472011.56 schema:affiliation grid-institutes:grid.410786.c
259 schema:familyName Ako
260 schema:givenName Junya
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744472011.56
262 rdf:type schema:Person
263 sg:pub.10.1186/s12933-018-0758-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106156906
264 https://doi.org/10.1186/s12933-018-0758-0
265 rdf:type schema:CreativeWork
266 sg:pub.10.1186/s12933-019-0827-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1112673031
267 https://doi.org/10.1186/s12933-019-0827-z
268 rdf:type schema:CreativeWork
269 grid-institutes:grid.410786.c schema:alternateName Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan
270 schema:name Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0373, Sagamihara, Kanagawa, Japan
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...